Garopride 50 mg 30 tablets
Eva Pharma
Eva Pharma
Composition
Each tablet contains
Active ingredient: Itopride hydrochloride – 50 mg
Product Description
Garopride is a gastroprokinetic medicine for oral use.
It improves gastric motility and coordination by increasing acetylcholine levels in the gastrointestinal tract.
The immediate‑release tablet form ensures rapid onset of action.
Garopride also has antiemetic properties due to its effect on dopamine receptors in the brain.
Indications for Use
Treatment of gastrointestinal symptoms associated with impaired gastric motility or delayed gastric emptying, such as:
Abdominal bloating,
Early satiety,
Postprandial fullness,
Epigastric pain or discomfort,
Loss of appetite,
Heartburn,
Nausea,
Vomiting Functional (non‑ulcer) dyspepsia or chronic gastritis.
Method of Administration and Dosage
Adults: 1 tablet (50 mg) orally, 3 times daily before meals.
Recommended daily dose: 150 mg.
Dose may be reduced depending on age and symptoms.
Clinical studies: treatment duration up to 8 weeks.
Contraindications
Gastrointestinal bleeding, mechanical obstruction, or perforation.
Pregnancy.
Lactation (breastfeeding).
Children under 16 years (safety data unavailable).
Hypersensitivity to itopride or excipients.
Precautions
Itopride enhances acetylcholine activity and may cause cholinergic adverse reactions.
Adverse Reactions (Side Effects)
Gastrointestinal: common – abdominal pain, diarrhea;
uncommon – hypersalivation
Laboratory findings: uncommon – elevated ALT, leukopenia
Nervous system: uncommon – dizziness, headache
Skin: uncommon – rash
Pregnancy and Lactation
Not recommended during pregnancy or breastfeeding.
Storage Conditions
Store at temperatures not exceeding 30°C.
Packaging
Carton box containing 3 blisters of 10 tablets each, with paper leaflet.